Mirati Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Mirati Therapeutics shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Mirati Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mirati Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Mirati Therapeutics by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $11M | 188k | 58.75 |
2023-09-30 | $7.2M | 165k | 43.56 |
2023-06-30 | $5.3M | 148k | 36.13 |
2023-03-31 | $4.0M | 107k | 37.18 |
2022-12-31 | $7.2M | 159k | 45.31 |
2022-09-30 | $1.5M | 21k | 69.67 |
2022-06-30 | $3.3M | 50k | 66.99 |
2022-03-31 | $643k | 8.0k | 80.00 |
2021-12-31 | $6.7M | 46k | 146.70 |
2021-09-30 | $5.6M | 32k | 176.93 |
2021-06-30 | $823k | 5.1k | 161.47 |
2021-03-31 | $1.7M | 10k | 171.24 |
2020-12-31 | $3.1M | 14k | 219.50 |
2020-09-30 | $2.1M | 13k | 166.20 |
2020-06-30 | $2.8M | 25k | 114.20 |
2020-03-31 | $1.2M | 16k | 76.85 |
2019-12-31 | $2.3M | 18k | 128.78 |
2019-09-30 | $6.5M | 83k | 77.90 |
2019-06-30 | $2.1M | 21k | 103.13 |
2019-03-31 | $220k | 3.0k | 72.77 |
2018-12-31 | $7.4M | 175k | 42.36 |
2018-09-30 | $1.4M | 29k | 46.96 |
2018-06-30 | $121k | 2.5k | 48.28 |
2018-03-31 | $1.8M | 60k | 30.52 |
2017-12-31 | $460k | 25k | 18.25 |
2017-09-30 | $171k | 15k | 11.71 |
2017-06-30 | $93k | 25k | 3.67 |
2017-03-31 | $117k | 23k | 5.21 |
2016-12-31 | $129k | 27k | 4.75 |
2016-09-30 | $142k | 22k | 6.60 |
2016-06-30 | $121k | 22k | 5.52 |
2016-03-31 | $429k | 20k | 21.38 |
2015-12-31 | $1.2M | 39k | 31.60 |
2015-09-30 | $596k | 17k | 35.71 |
2015-03-31 | $581k | 20k | 29.30 |